Clinical outcome of incidentally discovered small renal cell carcinoma after delayed surgery
暂无分享,去创建一个
H. Uemura | T. Oki | K. Sugimoto | T. Ohzeki | Shogo Adomi | K. Nose | A. Esa | T. Nishioka | Nobutaka Shimizu
[1] R. Uzzo,et al. Active surveillance of small renal masses , 2013, Nature Reviews Urology.
[2] B. Lane,et al. Growth kinetics and active surveillance for small renal masses , 2012, Current opinion in urology.
[3] Md. Shad Akhtar,et al. Active surveillance of small renal masses offers short‐term oncological efficacy equivalent to radical and partial nephrectomy , 2012, BJU international.
[4] R. Thompson,et al. Approach to the small renal mass: to treat or not to treat. , 2012, The Urologic clinics of North America.
[5] R. Uzzo,et al. Small renal masses progressing to metastases under active surveillance , 2012, Cancer.
[6] A. Evans,et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. , 2011, European urology.
[7] L. Klotz,et al. Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. , 2011, European urology.
[8] J. Richie,et al. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer. , 2010, European urology.
[9] J. Patard,et al. Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis. , 2009, The Journal of urology.
[10] S. Boorjian,et al. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance , 2009, Cancer.
[11] K. Bensalah,et al. A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. , 2009, European urology.
[12] O. Hes,et al. Tumours in end-stage kidney. , 2008, Transplantation proceedings.
[13] R. Uzzo,et al. Predicting growth of solid renal masses under active surveillance. , 2008, Urologic oncology.
[14] M. Kattan,et al. Preoperative nomogram predicting 12-year probability of metastatic renal cancer. , 2008, The Journal of urology.
[15] R. Uzzo,et al. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. , 2008, The Journal of urology.
[16] R. Uzzo,et al. Enhancing renal masses with zero net growth during active surveillance. , 2007, The Journal of urology.
[17] Rebecca M. Lindell,et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. , 2007, Radiology.
[18] S. Bhayani,et al. Pathological features of renal neoplasms classified by size and symptomatology. , 2006, The Journal of urology.
[19] H. Klingler,et al. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. , 2006, The Journal of urology.
[20] A. Hanlon,et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. , 2006, The Journal of urology.
[21] J. Lam,et al. Changing concepts in the surgical management of renal cell carcinoma. , 2004, European urology.
[22] K. Marumo,et al. Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer. , 2004, Japanese journal of clinical oncology.
[23] J. Cheville,et al. Solid renal tumors: an analysis of pathological features related to tumor size. , 2003, The Journal of urology.
[24] P. Warde,et al. Impact of Noninvasive Imaging on Increased Incidental Detection of Renal Cell Carcinoma , 2000, European Urology.
[25] M. Uder,et al. [Value of ultrasound in early diagnosis of renal cell carcinoma]. , 2000, Der Urologe. Ausg. A.
[26] A. Novick,et al. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. , 1999, The Journal of urology.
[27] J L Warren,et al. Rising incidence of renal cell cancer in the United States. , 1999, JAMA.
[28] H. Kosmehl,et al. Increase of Renal Cell Carcinoma Incidence in Central Europe , 1998, European Urology.
[29] A. Heidland,et al. Cancer in End-Stage Renal Disease: Potential Factors Involved , 1998, American Journal of Nephrology.
[30] A. Cassoni. Tnm Classification of Malignant Tumours , 1987 .
[31] Mordecai Schwartz. A biomathematical approach to clinical tumor growth , 1961, Cancer.
[32] Leslie H. Sobin,et al. TNM Classification of Malignant Tumours, 7th Edition , 2009 .
[33] J. Lynch,et al. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. , 2002, The Journal of urology.
[34] P. Choyke,et al. Acquired cystic kidney disease , 2000, European Radiology.